Interesting call. Questions lead to the following revelations.
1/ a US trip is planned in 2 weeks which may result in others warming to our technology, our candidates, and platform.
2/we could get a hint of a result within or after 6 months from the first dosing of the drug.
3/ the general market malaise in our space is making a rerate quite difficult to pick, but we should be worth more than a year ago all things being equal.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |